CIVAS (Community IntraVenous Antibiotic Study) looks at improving UK implementation and reduced geographic variation in community intravenous (IV) antibiotic services. There is a paucity of information upon which the National Health Service (NHS) can base decisions regarding the design, supply and commissioning of such services and upon which national guidance developers can base recommendations for best practice. The research addresses significant gaps in knowledge about the cost effectiveness of different IV antibiotic service models, identifies through choice modelling work which services patients prefer and which aspects of the services are most important to them. The evidence generated by the research will be used to help identify the optimal configuration of services in terms of value for money and patient preference.
CMC members involved: David Meads & Stephane Hess